PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study identifies key molecules in multiple myeloma

2010-10-27
(Press-News.org) COLUMBUS, Ohio – New research links three molecules to a critical tumor suppressor gene that is often turned off in multiple myeloma, a presently incurable cancer of the blood.

The findings might offer a new strategy for treating this disease and other blood cancers, according to researchers at The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) who led the study.

The silenced molecules are called miR-192, miR-194 and miR-215. All of them are microRNAs, a large class of molecules that are master regulators of many important cell processes.

The study, published in the Oct. 19 issue of Cancer Cell, suggests that re-activating these three molecules triggers expression of the P53 tumor suppressor gene. This, in turn, slows the growth and leads to the death of myeloma cells and could provide a new strategy for treating the disease.

"These findings provide a rationale for the further exploration of these microRNAs as a treatment for multiple myeloma, which has few therapeutic options," says principal investigator Dr. Carlo Croce, professor and chair of Molecular Virology, Immunology and Medical Genetics, and director of the Human Cancer Genetics program at the OSUCCC – James.

Multiple myeloma is a disorder of white blood cells called plasma cells. More than 20,100 Americans are expected to develop the disease this year and some 10,600 are expected to die from it. Myeloma begins as a benign condition called monoclonal gammopathy of undetermined significance (MGUS). Individuals with MGUS can live for many years without treatment. Then, for unknown reasons, this benign condition can evolve into multiple myeloma.

Studies investigating the molecular causes of the disease have shown a relationship between P53 and another gene called MDM2. They have also shown that myeloma cells often have healthy (i.e., unmutated) P53 genes but very little P53 protein. P53 protein levels are restored, however, when MDM2 expression is blocked.

The study by Croce and his collaborators, which examines the role of microRNA in regulating the P53 pathway in myeloma cells, shows the following: Expression of miR-192, miR-194 and miR-215 in multiple myeloma cells slows their growth and causes their death by activating the P53 gene. Multiple myeloma cells from patients show high MDM2 expression compared with MGUS cells and normal plasma cells; Expression of the three microRNAs dramatically lowers MDM2 expression levels and significantly increases P53 levels; Treating myeloma cells with the three microRNAs plus an MDM2 inhibitor caused a two-fold rise in P53 expression and a three-fold drop in MDM2 expression; Treating a myeloma mouse model with the three microRNAs caused a 50 percent reduction in tumor size compared with controls; treating the mice with the microRNAs plus an MDM2 inhibitor brought a five-fold reduction in tumor size. Expression of the three microRNAs reduced the ability of myeloma cells to migrate and metastasize.

Overall, Croce says, "our results provide the basis for developing a microRNA-based therapy for multiple myeloma."

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

New entitlement program not a replacement for long-term care insurance

New entitlement program not a replacement for long-term care insurance
2010-10-27
CHAMPAIGN, Ill. – An obscure provision in the health care reform bill has the potential to seriously alter the long-term care landscape for older Americans, but it may not be as beneficial to retirees as it will be for near-retirees and successive generations of workers, new research by a University of Illinois elder law expert warns. Richard L. Kaplan, an expert on federal taxes and retirement issues, says the new federal entitlement program, known as Community Living Assistance Services and Supports, or CLASS, shouldn't be viewed as a replacement for long-term care ...

Targeted radiation therapy minimizes GI side effects for prostate cancer patients, Penn study shows

2010-10-27
SAN DIEGO -- Prostate cancer patients who receive intensity modulated radiation therapy (IMRT) are less apt to suffer serious gastrointestinal complications following their treatment than those who receive three-dimensional conformal radiotherapy (CRT), according to new research from the University of Pennsylvania School of Medicine. The study, which will be presented Nov. 1 at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Diego, found that men who were treated with IMRT had fewer serious bowel complications, including painful rectal ...

School attendance, refusal skills combat smoking risk in youth

2010-10-27
COLUMBIA, Mo. – Asian-American youth are one of the fastest growing populations in the United States. Although Asian Americans begin smoking later in life, they are more likely to smoke regularly and at a higher rate than other ethnic or racial groups, according to the Department of Health and Human Services. Now, a University of Missouri researcher is examining the unique differences in adolescent tobacco use among Asians and other groups to provide specific recommendations for prevention and treatment. "Given the large number of addicted teenagers, tobacco control ...

Tornado warnings are too often ignored

2010-10-27
EAST LANSING, Mich. — With big storms ripping across the Midwest, Bob Drost is hoping people are paying attention to the severe weather and tornado warnings. Unfortunately, Drost, a doctoral student at Michigan State University, knows that many times those warnings are ignored, according to his research. "Only 63 percent understood that a warning is the most urgent National Weather Service statement during severe weather," he said. Next week, Drost will present his research findings at the Geological Society of America's annual conference to fellow earth scientists ...

Study raises concern about ability of tests to predict fertility

2010-10-27
CHAPEL HILL – The method used to assess infertility in at-home tests might not be the best for identifying which women will have trouble getting pregnant, according to new research from the University of North Carolina at Chapel Hill School of Medicine. The study found that the cutoffs used by such infertility tests, which measure levels of a molecule called follicle stimulating hormone or FSH, label many women as infertile who actually go on to have children naturally. It also suggests that another hormone, called antimullerian hormone or AMH, could prove to be a much ...

Breakthrough in understanding life-threatening childhood liver disease

2010-10-27
Researchers at the University of Colorado School of Medicine and The Children's Hospital have taken a big step toward understanding what causes one of the most serious liver diseases in infants. The disease is called biliary atresia, It blocks the bile ducts in young infants, through which bile, crucial for digestion, flows to the small intestine. The disease is rare – it strikes in about one in 10,000 births. But it's life-threatening. "It is fatal if not treated quickly," says Cara Mack, MD, who led the CU research. Surgical removal of the blocked main bile duct ...

Breaching the breech protocol

2010-10-27
Most babies are delivered head-first, but in about 4% of all deliveries babies are "born breech" ― with their buttocks or feet first. Doctors usually exercise caution and use caesarean sections (C-sections) as the delivery method of choice for such births, believing it safer for the baby. After a large-scale international study in 2000, C-sections became the near-universal choice for such births. But now researchers at Tel Aviv University are saying that, under certain circumstances, traditional vaginal delivery for breech babies is not only safe for baby, but even ...

6 new isotopes of the superheavy elements discovered

2010-10-27
Berkeley, CA—A team of scientists at the U.S. Department of Energy's Lawrence Berkeley National Laboratory has detected six isotopes, never seen before, of the superheavy elements 104 through 114. Starting with the creation of a new isotope of the yet-to-be-named element 114, the researchers observed successive emissions of alpha particles that yielded new isotopes of copernicium (element 112), darmstadtium (element 110), hassium (element 108), seaborgium (element 106), and rutherfordium (element 104). Rutherfordium ended the chain when it decayed by spontaneous fission. ...

Haptoglobin as an early serum biomarker of virus-induced type 1 diabetes in rats

2010-10-27
Type 1 diabetes (T1D), formerly known as juvenile diabetes, is a multifactorial disease of complex etiology characterized by the autoimmune destruction of pancreatic beta cells. In addition to genetic susceptibility, it is generally accepted that environmental factors play important roles in triggering disease, with virus infection having perhaps the strongest association. Multiple viral infections including cytomegalovirus, mumps, rubella, enteroviruses, and parvovirus have all been associated with human T1D. Indeed, the effects of diverse viruses in triggering T1D may ...

USDA scientists helping keep in-demand smoked salmon safe to eat

2010-10-27
Scientists with the U.S. Department of Agriculture (USDA) are helping ensure that the smoked salmon that's always a hit at festive gatherings also is always safe to eat, including among their achievements the development of a first-of-its-kind mathematical model that food processors and others can use to select the optimal combination of temperature and concentrations of salt and smoke compounds to reduce or eliminate microbial contamination of the product. The studies are led by food technologist Andy (Cheng-An) Hwang with the USDA Agricultural Research Service's (ARS) ...

LAST 30 PRESS RELEASES:

Students with multiple marginalized identities face barriers to sports participation

Purdue deep-learning innovation secures semiconductors against counterfeit chips

Will digital health meet precision medicine? A new systematic review says it is about time

Improving eye tracking to assess brain disorders

Hebrew University’s professor Haitham Amal is among a large $17 million grant consortium for pioneering autism research

Scientists mix sky’s splendid hues to reset circadian clocks

Society for Neuroscience 2024 Outstanding Career and Research Achievements

Society for Neuroscience 2024 Early Career Scientists’ Achievements and Research Awards

Society for Neuroscience 2024 Education and Outreach Awards

Society for Neuroscience 2024 Promotion of Women in Neuroscience Awards

Baek conducting air quality monitoring & simulation analysis

Albanese receives funding for scholarship grant program

Generative AI model study shows no racial or sex differences in opioid recommendations for treating pain

New study links neighborhood food access to child obesity risk

Efficacy and safety of erenumab for nonopioid medication overuse headache in chronic migraine

Air pollution and Parkinson disease in a population-based study

Neighborhood food access in early life and trajectories of child BMI and obesity

Real-time exposure to negative news media and suicidal ideation intensity among LGBTQ+ young adults

Study finds food insecurity increases hospital stays and odds of readmission 

Food insecurity in early life, pregnancy may be linked to higher chance of obesity in children, NIH-funded study finds

NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

New study reveals changes in the brain throughout pregnancy

15-minute city: Why time shouldn’t be the only factor in future city planning

Applied Microbiology International teams up with SelectScience

Montefiore Einstein Comprehensive Cancer Center establishes new immunotherapy institute

New research solves Crystal Palace mystery

Shedding light on superconducting disorder

Setting the stage for the “Frankfurt Alliance”

Alliance presents final results from phase III CABINET pivotal trial evaluating cabozantinib in advanced neuroendocrine tumors at ESMO 2024 and published in New England Journal of Medicine

X.J. Meng receives prestigious MERIT Award to study hepatitis E virus

[Press-News.org] Study identifies key molecules in multiple myeloma